CRISPR Therapeutics AG
METHODS OF MANUFACTURING CAR-T CELLS

Abstract:

Aspects of the present disclosure relate to methods for manufacturing genetically engineered T cells expressing a chimeric antigen receptor (CAR) that provide several improvements over conventional manufacturing methods, thereby enabling production of a robust supply of clinically useful CAR T-cell therapies.